These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 17517872)

  • 1. Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection.
    Torrado E; Adusumilli S; Fraga AG; Small PL; Castro AG; Pedrosa J
    Infect Immun; 2007 Aug; 75(8):3979-88. PubMed ID: 17517872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for an intramacrophage growth phase of Mycobacterium ulcerans.
    Torrado E; Fraga AG; Castro AG; Stragier P; Meyers WM; Portaels F; Silva MT; Pedrosa J
    Infect Immun; 2007 Feb; 75(2):977-87. PubMed ID: 17145944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma-dependent activation of macrophages during experimental infections by Mycobacterium ulcerans is impaired by the toxin mycolactone.
    Torrado E; Fraga AG; Logarinho E; Martins TG; Carmona JA; Gama JB; Carvalho MA; Proença F; Castro AG; Pedrosa J
    J Immunol; 2010 Jan; 184(2):947-55. PubMed ID: 20008288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo.
    Adusumilli S; Mve-Obiang A; Sparer T; Meyers W; Hayman J; Small PL
    Cell Microbiol; 2005 Sep; 7(9):1295-304. PubMed ID: 16098217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice.
    Oliveira MS; Fraga AG; Torrado E; Castro AG; Pereira JP; Filho AL; Milanezi F; Schmitt FC; Meyers WM; Portaels F; Silva MT; Pedrosa J
    Infect Immun; 2005 Oct; 73(10):6299-310. PubMed ID: 16177301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin.
    Coutanceau E; Marsollier L; Brosch R; Perret E; Goossens P; Tanguy M; Cole ST; Small PL; Demangel C
    Cell Microbiol; 2005 Aug; 7(8):1187-96. PubMed ID: 16008585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs.
    Hong H; Coutanceau E; Leclerc M; Caleechurn L; Leadlay PF; Demangel C
    PLoS Negl Trop Dis; 2008; 2(10):e325. PubMed ID: 18941518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans: implications for virulence.
    Mve-Obiang A; Lee RE; Portaels F; Small PL
    Infect Immun; 2003 Feb; 71(2):774-83. PubMed ID: 12540557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.
    Fraga AG; Martins TG; Torrado E; Huygen K; Portaels F; Silva MT; Castro AG; Pedrosa J
    PLoS One; 2012; 7(3):e33406. PubMed ID: 22413022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence.
    George KM; Chatterjee D; Gunawardana G; Welty D; Hayman J; Lee R; Small PL
    Science; 1999 Feb; 283(5403):854-7. PubMed ID: 9933171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in virulence and immune response induced in a murine model by isolates of Mycobacterium ulcerans from different geographic areas.
    Ortiz RH; Leon DA; Estevez HO; Martin A; Herrera JL; Romo LF; Portaels F; Pando RH
    Clin Exp Immunol; 2009 Aug; 157(2):271-81. PubMed ID: 19604267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycolactone gene expression is controlled by strong SigA-like promoters with utility in studies of Mycobacterium ulcerans and buruli ulcer.
    Tobias NJ; Seemann T; Pidot SJ; Porter JL; Marsollier L; Marion E; Letournel F; Zakir T; Azuolas J; Wallace JR; Hong H; Davies JK; Howden BP; Johnson PD; Jenkin GA; Stinear TP
    PLoS Negl Trop Dis; 2009 Nov; 3(11):e553. PubMed ID: 19936295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A newly discovered mycobacterial pathogen isolated from laboratory colonies of Xenopus species with lethal infections produces a novel form of mycolactone, the Mycobacterium ulcerans macrolide toxin.
    Mve-Obiang A; Lee RE; Umstot ES; Trott KA; Grammer TC; Parker JM; Ranger BS; Grainger R; Mahrous EA; Small PL
    Infect Immun; 2005 Jun; 73(6):3307-12. PubMed ID: 15908356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FVB/N Mice Spontaneously Heal Ulcerative Lesions Induced by Mycobacterium ulcerans and Switch M. ulcerans into a Low Mycolactone Producer.
    Marion E; Jarry U; Cano C; Savary C; Beauvillain C; Robbe-Saule M; Preisser L; Altare F; Delneste Y; Jeannin P; Marsollier L
    J Immunol; 2016 Mar; 196(6):2690-8. PubMed ID: 26873988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone.
    Coutanceau E; Decalf J; Martino A; Babon A; Winter N; Cole ST; Albert ML; Demangel C
    J Exp Med; 2007 Jun; 204(6):1395-403. PubMed ID: 17517970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice.
    Bieri R; Bolz M; Ruf MT; Pluschke G
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004450. PubMed ID: 26863011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced Synthesis of Mycolactone Restores the Pathogenesis of
    Strong E; Hart B; Wang J; Orozco MG; Lee S
    Front Immunol; 2022; 13():750643. PubMed ID: 35401531
    [No Abstract]   [Full Text] [Related]  

  • 18. The One That Got Away: How Macrophage-Derived IL-1β Escapes the Mycolactone-Dependent Sec61 Blockade in Buruli Ulcer.
    Hall BS; Hsieh LT; Sacre S; Simmonds RE
    Front Immunol; 2021; 12():788146. PubMed ID: 35154073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buruli ulcer: emerging from obscurity.
    Wansbrough-Jones M; Phillips R
    Lancet; 2006 Jun; 367(9525):1849-58. PubMed ID: 16753488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathogenic mechanism of the Mycobacterium ulcerans virulence factor, mycolactone, depends on blockade of protein translocation into the ER.
    Hall BS; Hill K; McKenna M; Ogbechi J; High S; Willis AE; Simmonds RE
    PLoS Pathog; 2014 Apr; 10(4):e1004061. PubMed ID: 24699819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.